Soleno Therapeutics
(NASDAQ) SLNO
Soleno Therapeutics Financials at a Glance
Market Cap
$1.71B
Revenue (TTM)
$190.41M
Net Income (TTM)
$20.89M
EPS (TTM)
$0.22
P/E Ratio
149.04
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$31.80
Volume
40,721
Open
$34.05
Price
$31.80
Volume
40,721
Open
$34.05
Previous Close
$31.80
Daily Range
$31.80 - $34.05
52-Week Range
$31.71 - $90.32
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$31.80
Volume
40,721
Open
$34.05
Previous Close
$31.80
Daily Range
$31.80 - $34.05
52-Week Range
$31.71 - $90.32
SLNO News
SLNO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Soleno Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
182
CEO
Anish Bhatnagar, MD
Website
www.soleno.lifeHeadquarters
Redwood City, CA 94065, US
SLNO Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
5%
Net Income Margin
11%
Return on Equity
6%
Return on Capital
2%
Return on Assets
4%
Earnings Yield
0.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.71B
Shares Outstanding
51.62M
Volume
40.72K
Short Interest
0.00%
Avg. Volume
1.54M
Financials (TTM)
Gross Profit
$187.71M
Operating Income
$14.95M
EBITDA
$28.38M
Operating Cash Flow
$46.80M
Capital Expenditure
$73.00K
Free Cash Flow
$46.73M
Cash & ST Invst.
$305.47M
Total Debt
$2.69M
Soleno Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$91.73M
N/A
Gross Profit
$90.87M
N/A
Gross Margin
99.06%
N/A
Market Cap
$1.71B
N/A
Market Cap/Employee
$14.91M
N/A
Employees
115
N/A
Net Income
$43.36M
+177.4%
EBITDA
$45.22M
+191.4%
Quarterly Fundamentals
Net Cash
$302.78M
+26.9%
Accounts Receivable
$28.21M
N/A
Inventory
$15.02M
N/A
Long Term Debt
$1.96M
-96.2%
Short Term Debt
$726.00K
+38.0%
Return on Assets
3.71%
N/A
Return on Invested Capital
2.04%
N/A
Free Cash Flow
$48.65M
+302.7%
Operating Cash Flow
$48.70M
+303.0%